Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001396814-25-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-06 | 2025-01-02 | PCRX | Lee Frank D. | CEO, Dir | F - Tax | $18.33 | -9,375 | 98.4K | -9% | -$171.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | F | D | 9,375 | $18.33 | 98,409 | D | — | — |